Skip to content

Evaluating a Physical Activity Index for Assessment and Counseling for Breast and Colon Cancer Survivors

Evaluating a Physical Activity Index for Assessment and Counseling for Breast and Colon Cancer Survivors in Clinical Practice

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06340503
Enrollment
20
Registered
2024-04-01
Start date
2024-11-06
Completion date
2026-06-08
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Colon Cancer

Keywords

Physical activity, Exercise coaching

Brief summary

The purpose of this research study is to determine whether using the physical activity index screener, exercise coaching, and self-monitoring will increase physical activity and reduce time spent sitting or being inactive in patients who had breast or colon cancer.

Detailed description

To assess the feasibility (participation rate, adherence, and retention) of the Physical Activity Index (PAI) intervention in breast and colon cancer survivors supported by exercise coaching and self-monitoring tools.

Interventions

DEVICEResearch-grade accelerometer

Participants will be instructed to wear device for 7 days prior to each visit and to bring the device to each visit. Study staff will extract data from the device within 14 days after each appointment and return the device to patients by mail.

OTHERNational Comprehensive Cancer Network (NCCN) Education Materials

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) are comprised of recommendations for the prevention, diagnosis, and management of malignancies across the continuum of care.

This device can automatically capture and classify different physical activities such as walking, running, biking, swimming and using an elliptical.

OTHERExercise Consultation Calls

The intervention group will receive five monthly exercise consultation calls with an exercise coach in between clinical visits and be provided with an exercise log for their personal use

OTHERInterview

The interviews will be conducted by a trained Q-PRO interviewer and audio recorded. Interviews are expected to last approximately 30 minutes. Discussion will include acceptability of the PAI intervention, related tools, and clinical experiences and will help shape/inform refinements need for a larger efficacy trial

OTHERPhysical Activity Index Assessment (Intervention Arm)

Assessment will capture frequency and time spent in strenuous, moderate, and mild PA over the past 7 days. Survivors also report hours of TV or similar sedentary screen time per week as a measure of sedentary behavior. Completed at months 1, 3, 6, 9 and 12 while on study

OTHERPhysical Activity Index Assessment (Control Arm)

Assessment will capture frequency and time spent in strenuous, moderate, and mild PA over the past 7 days. Survivors also report hours of TV or similar sedentary screen time per week as a measure of sedentary behavior. Completed at months 6, 9 and 12 while on study.

Various health surveys will be completed to assess participant health and physical activities.

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Survivors of breast or colon cancer (stages 0-III) diagnosed within the last three years prior to enrollment. * Completed primary treatment (surgery, chemotherapy, and/or radiation) at least 3 months prior to enrollment. * At least 50 years of age or older. * Access to internet or cellular plan for video calls. * Being willing and able to comply with the approved protocol and able to sign an IRB-approved informed consent document directly, remotely or via electronic consent. * Able to read and speak English

Exclusion criteria

* Participants with metastatic disease. * Participants with recurrence or diagnosis of a different cancer. * Participants receiving treatment other than maintenance therapy for their primary cancer (breast or colon). * Participants has prior conditions that contraindicate exercise as determined by treating physician. * Participants has gross cognitive impairment as determined by treating physician.

Design outcomes

Primary

MeasureTime frameDescription
Number of Eligible Participants - Participation Rate17 monthsParticipation will be measured by the number of eligible participants who agree to participate. Investigators will calculate 95% confidence interval for each of the feasibility measures to determine the range of estimates that are consistent with the data.
Percentage of Participants to Complete Exercise Sessions - Adherence17 monthsAdherence will be measured by the percent of participants who complete at least 3 out 5 exercise sessions. Investigators will calculate 95% confidence interval for each of the feasibility measures to determine the range of estimates that are consistent with the data.
Number of Participants Who Complete Study Questionnaires - RetentionAt baseline and up to 17 monthsRetention will be defined as the number of participants who complete study questionnaires at baseline and one follow-up timepoint. Investigators will calculate 95% confidence interval for each of the feasibility measures to determine the range of estimates that are consistent with the data.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORShirley Bluethmann

Wake Forest Baptist Comprehensive Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 30, 2026